Becton Dickinson and CompanyBDX

BDX current price
$224.80-5.00%

Capital at risk.

1W
-3.07%
1M
-3.23%
3M
+0.79%
6M
-3.86%
1Y
-5.00%
MAX
+83.27%
About Becton Dickinson and Company
Ticker
info
BDX
Trading on
info
NYSE
ISIN
info
US0758871091
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Thomas E. Polen Jr.
Headquarters
info
1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880
Employees
info
70,000
Website
info
bd.com
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Metrics
BasicAdvanced
Market cap
info
$64.6B
P/E ratio
info
37.88
EPS
info
$5.94
Dividend Yield
info
1.75%
Beta
info
0.45
Forward P/E ratio
info
16.13
EBIDTA
info
$5.11B
Ex dividend date
info
2024-12-09
Price & volume
Market cap
info
$64.6B
Average daily volume
info
2.2M
90-day return
info
0.79%
30-day return
info
-3.23%
7-day return
info
-3.07%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
1.75%
Forward dividend per share
info
$3.89
Forward dividend yield
info
1.75%
Payout ratio
info
27.97%
Valuation
P/E ratio
info
37.88
Forward P/E
info
16.13
PEG ratio
info
1.03
Trailing P/E
info
37.88
Price to sales
info
3.26
Price to book
info
2.57
Earnings
EPS
info
$5.94
EPS estimate (current quarter)
info
$2.99
EPS estimate (next quarter)
info
$3.45
EBITDA
info
$5.11B
Revenues (TTM)
info
$19.8B
Revenues per share (TTM)
info
$68.37
Technicals
Beta
info
0.45
52-week High
info
$251.99
52-week Low
info
$216.83
50-day moving average
info
$231.69
200-day moving average
info
$233.72
Short ratio
info
1.42
Short %
info
0.73%
Management effectiveness
ROE (TTM)
info
5.63%
ROA (TTM)
info
3.25%
Profit margin
info
7.13%
Gross profit margin
info
$8.9B
Operating margin
info
15.19%
Growth
Quarterly earnings growth (YoY)
info
290.10%
Quarterly revenue growth (YoY)
info
6.90%
Share stats
Outstanding Shares
info
287M
Float
info
288M
Insiders %
info
0.28%
Institutions %
info
91.75%
Analyst Insights & forecasts
info

84% Buy

16% Hold

0% Sell

Based on information from 18 analysts.

Average price target

info
$276.58
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$3.17
$2.97
6.73%
Q1 • 24Beat
$3.50
$3.31
5.74%
Q2 • 24Beat
$3.81
$3.77
1.06%
Q3 • 24Beat
$3.43
$2.99
14.73%
Q4 • 24Beat
-
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$5.44B
$400M
7.36%
Q3 • 24
$5.17B
$303M
5.86%
Q4 • 24
4.95%
24.25%
20.31%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$57.3B
$31.4B
54.81%
Q3 • 24
$54.7B
$29.5B
53.89%
Q4 • 24
4.58%
6.17%
1.67%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$1.18B
$-3.94B
$124M
$882M
Q3 • 24
$693M
$204M
$-1.93B
$588M
Q4 • 24
41.17%
105.18%
1,654.84%
33.33%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.50

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Becton Dickinson and Company share?
Collapse

Becton Dickinson and Company shares are currently traded for $224.80 per share.

How many shares does Becton Dickinson and Company have?
Collapse

Becton Dickinson and Company currently has 287M shares.

Does Becton Dickinson and Company pay dividends?
Collapse

No, Becton Dickinson and Company doesn't pay dividends.

What is Becton Dickinson and Company 52 week high?
Collapse

Becton Dickinson and Company 52 week high is $251.99.

What is Becton Dickinson and Company 52 week low?
Collapse

Becton Dickinson and Company 52 week low is $216.83.

What is the 200-day moving average of Becton Dickinson and Company?
Collapse

Becton Dickinson and Company 200-day moving average is $233.72.

Who is Becton Dickinson and Company CEO?
Collapse

The CEO of Becton Dickinson and Company is Thomas E. Polen Jr..

How many employees Becton Dickinson and Company has?
Collapse

Becton Dickinson and Company has 70,000 employees.

What is the market cap of Becton Dickinson and Company?
Collapse

The market cap of Becton Dickinson and Company is $64.6B.

What is the P/E of Becton Dickinson and Company?
Collapse

The current P/E of Becton Dickinson and Company is 37.88.

What is the EPS of Becton Dickinson and Company?
Collapse

The EPS of Becton Dickinson and Company is $5.94.

What is the PEG Ratio of Becton Dickinson and Company?
Collapse

The PEG Ration of Becton Dickinson and Company is 1.03.

What do analysts say about Becton Dickinson and Company?
Collapse

According to the analysts Becton Dickinson and Company is considered a buy.